Endeavor

The Promise of Radiopharmaceuticals

Breakthrough therapies deliver radiation directly to cancer cells while minimizing harm to surrounding healthy tissue

Honoring Service and Survival

Air Force Veteran and cancer survivor honored at Moffitt’s Veterans Day ceremony

Five Years of Progress, Purpose and Possibility

Celebrating the milestones, growth and teamwork that define CEO Dr. Patrick Hwu’s leadership at Moffitt

Many Breast Cancer Patients Don’t Need Radiation After Surgery

Trial results show radiation to chest wall made no difference in survival in early stage patients

Combination Therapy Before Surgery Shows Promise for Aggressive Skin Cancer

Moffitt-led study explores how pairing lenvatinib and pembrolizumab strengthens immune response against Merkel cell carcinoma

Experimental Injectable Therapy Offers Nonsurgical Treatment of Common Skin Cancer

Phase 2 study led by Moffitt researchers finds VP-315 triggers strong local and systemic immune response against basal cell carcinoma

TIL Therapy Research Expanded to Bladder Cancer

Almost half of patients enrolled in a Moffitt trial responded to the cellular immunotherapy

On Course for a Full Life

After beating oropharynx cancer, Eric Bilow shows there’s no challenge he won’t take on

Moffitt’s McKinley Outpatient Center Celebrates 10th Anniversary

Even a decade after its opening, the campus continues to evolve